Steven Robert Schuster, Saulius Girnius, Rayan Kaedbey, Paola Ochoa, Ludek Pour, Ronan Le Calloch, Tobias S. Slørdahl, Ann De Becker, Fangxin Hong, Margaret Hoyle, Anne Yver, Gregory Finn, Thomas Chalopin. "MagnetisMM-32: A phase 3 randomized study of elranatamab vs EPd, PVd, or Kd in patients with relapsed or refractory multiple myeloma (RRMM) and prior anti-CD38–directed therapy.." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.16_suppl.tps7568